Sun Pharma Canada Inc.

FDA inspection history across 2 sites, 2008 to 2022

1
Form 483
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2008: one warning letter; 2022: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2008One warning letter, at Hawthorne, New York.
  2. 2022One Form 483, at Brampton, Canada.

Cited most

Across all Sun Pharma Canada observations on file

The complete Sun Pharma Canada file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2022-09-16483 Form 483$99
2008-07-31Warning letter Warning letter$99

Investigators on these documents

Marian E. Ramirez (1)

FEI number 3002808384 · most recent document Sep 16, 2022

About Sun Pharma Canada Inc.

How many FDA Form 483s has Sun Pharma Canada Inc. received?

FDA Intel has 1 Form 483 on file for Sun Pharma Canada Inc.; the most recent is dated Sep 16, 2022.

When was Sun Pharma Canada Inc. last inspected by FDA?

The most recent FDA inspection document on file for Sun Pharma Canada Inc. is a Form 483 dated Sep 16, 2022, for the site in Brampton, Canada.

What did FDA cite at Sun Pharma Canada Inc.?

The regulations cited most in the observations on file for Sun Pharma Canada Inc. are 21 CFR 211.100(b) (Written procedures; deviations), 1 time; 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time.

Has Sun Pharma Canada Inc. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Sun Pharma Canada Inc.; the most recent is dated Jul 31, 2008.